Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biohit Oyj to start clinical trial with Acetium lozenge aimed at smoking cessation


Friday, 29 Nov 2013 02:00am EST 

Biohit Oyj:Says the company is to start a clinical intervention trial with Acetium lozenge aimed at smoking cessation.Says the aim of the study is to assess the effectiveness of Acetium lozenge in this new indication i.e. to reduce nicotine dependence, and help with smoking cessation and/or reduction.Says the study will be conducted as a placebo-controlled, double-blind, randomized trial where half of the subjects will receive the active compound and the other half will receive a placebo.Says the trial will be conducted in Helsinki, Finland. 

Company Quote

5.54
 --
24 Oct 2014